An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer

Daniel Morgensztern, Nina Karaseva, Enriqueta Felip, Ignacio Delgado, Olga Burdaeva, Manuel Dómine, Primo Lara, Paul K. Paik, Ulrik Lassen, Sergey Orlov, José Trigo, Marina Shomova, Katherine Baker-Neblett, James Vasquez, Xiaowei Wang, Li Yan, Ionel Mitrica, M. Phillip DeYoung, Pilar Garrido

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint Dive into the research topics of 'An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences